0001593968-22-001243.txt : 20220713 0001593968-22-001243.hdr.sgml : 20220713 20220713173351 ACCESSION NUMBER: 0001593968-22-001243 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220711 FILED AS OF DATE: 20220713 DATE AS OF CHANGE: 20220713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HO WILLIAM CENTRAL INDEX KEY: 0001400901 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 221081731 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 primary_01.xml PRIMARY DOCUMENT X0306 4 2022-07-11 0001673772 RAPT Therapeutics, Inc. RAPT 0001400901 HO WILLIAM C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Medical Officer Common Stock 2022-07-11 4 S false 2000 19.95 D 52306 D Common Stock 2022-07-11 4 M false 1041 6.3 A 53347 D Common Stock 2022-07-11 4 M false 1381 12 A 54728 D Option (right to buy) 6.30 2022-07-11 4 M false 1041 0 D 2029-03-27 Common Stock 1041 2084 D Option (right to buy) 12 2022-07-11 4 M false 1381 0 D 2029-10-29 Common Stock 1381 7361 D Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. /s/ Rodney Young, Attorney-in-Fact for William Ho 2022-07-13